Effect of daily azithromycin therapy and adherence on readmission risk in COPD

Eur Respir J. 2019 Mar 18;53(3):1801377. doi: 10.1183/13993003.01377-2018. Print 2019 Mar.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Azithromycin / administration & dosage*
  • Female
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Patient Readmission / statistics & numerical data*
  • Proportional Hazards Models
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Respiratory Function Tests
  • Risk
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Azithromycin